Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contact Us Login 
An Official Publication of the Indian Association of Oral and Maxillofacial Pathologists


 
  Table of Contents    
REVIEW ARTICLE  
Year : 2020  |  Volume : 24  |  Issue : 2  |  Page : 361-367
 

Oral microbiome and oral cancer – The probable nexus


Department of Oral Pathology and Microbiology, Bharati Vidyapeeth (Deemed to be) University, Dental College and Hospital, Pune, Maharashtra, India

Date of Submission16-Jan-2020
Date of Decision18-May-2020
Date of Acceptance08-Jun-2020
Date of Web Publication09-Sep-2020

Correspondence Address:
Priya Nimish Deo
Department of Oral Pathology and Microbiology, Bharati Vidyapeeth Deemed to be University, Dental College and Hospital, Pune, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jomfp.JOMFP_20_20

Rights and Permissions

 

   Abstract 


Oral squamous cell carcinoma is one of the most common malignancies and is the leading cause of morbidity and mortality. The known risk factors for oral cancer are tobacco, alcohol consumption and betel quid chewing. Nutritional deficiencies and certain microorganisms are also associated with oral cancer. Oral cavity is a host to numerous microorganisms, majority of which are bacterial communities along with fungi and viruses. A possibility of the dysregulation of the oral microbiome cannot be ignored. Oral microbiome is defined as the collective genome of microorganisms that reside in the oral cavity. With the development of culture-independent techniques, the detection and identification of the bacteria which cannot be cultured has become possible. Revolution in technology has led to increased research in this area in an attempt to find the role of microbiome in health and disease. Before identifying the exact role the microbiome
plays in the development of oral cancer, it is essential to profile the microbiome in healthy individuals and patients with oral cancer. It is essential to note that oral cancer may sometimes occur without any habit too!! This article is an attempt to review the role of oral microbiome in oral cancer with a focus on the bacteriome, its related studies and in brief about the omics technologies in understanding the microbiome.


Keywords: Omics, oral cancer, oral microbiome


How to cite this article:
Deo PN, Deshmukh R. Oral microbiome and oral cancer – The probable nexus. J Oral Maxillofac Pathol 2020;24:361-7

How to cite this URL:
Deo PN, Deshmukh R. Oral microbiome and oral cancer – The probable nexus. J Oral Maxillofac Pathol [serial online] 2020 [cited 2020 Nov 1];24:361-7. Available from: https://www.jomfp.in/text.asp?2020/24/2/361/294612





   Introduction Top


The microbiome in humans is known to be associated with many different types of cancers in the body. Since the last two decades, bacteria have been implicated in the etiology of some cancers such as Helicobacter pylori in gastric cancer and mucosa-associated lymphoid tissue lymphomas, Chlamydia trachomatis in cervical cancer, Salmonella typhi in gallbladder cancer and Bacteroides fragilis and Fusobacterium nucleatum in colon cancer.[1],[2]

This has encouraged and triggered a considerable amount of research to identify the possible role of bacteria in oral carcinogenesis.[1]

Oral cancer is a multifactorial disease. Host genetics and environmental factors play a role in the causation of this disease. Tobacco, alcohol consumption, betel quid chewing and human papillomavirus (HPV) infections are well-known risk factors. A possible etiology could be attributed to the microbes in around 15% of oral cancer patients without known risk factors.[3]

The squamous epithelium of the oral cavity is continuously exposed to a variety of microbial challenges, at both cellular and molecular levels.[4]

There is a wide inter-individual diversity in microbial colonization in the oral cavity. This micro-environmental variability connected to the oral microbial flora is likely to modify tumor cell genotype and phenotype. This leads to heterogeneity in the tumor cells, a characteristic that might be quite exceptional for oral squamous cell carcinoma (OSCC) and not hold true for other cancers in the body.[5]

It is, therefore, justifiable to discuss the changes in the composition of the normal oral microbiome, which comprises of more than 600 different bacterial species. The changes in the composition of the oral microbiome are certainly associated with periodontal disease which is known to be a polymicrobial disease. Variations of oral bacterial and fungal microbiome have been noted in association with oral precancers and cancers. Chronic bacterial infections could promote or cause oral cancer.[6]

Theories which indicate a link between cancer and the micro-organisms have been studied in the last few decades.[7]

Specific bacteria have been identified that strongly correlate with OSCCs, such as Streptococcus, Peptostreptococcus, Prevotella, Porphyromonas gingivalis and Capnocytophaga gingivalis.[8]

Most research so far have been focused on the bacterial component of the oral microbiome – the oral bacteriome, as bacteria are the predominant microorganisms in the oral cavity. However, there is a growing interest in the less abundant microbial communities such as fungi and viruses.[9]

However, there is no consensus among the reports regarding changes in the oral microbiome in association with oral cancer; this is because previous studies were confined to the investigation of a relatively small number of known bacteria and bacteria which can be cultured. Culture-independent techniques, particularly next-generation sequencing (NGS) of the hypervariable region of the 16S ribosomal subunit, provides a means for more comprehensive and accurate profiling of the microbiome in health and disease.[6]


   Bacteria and Oral Carcinogenesis Top


Cancer has been described as a molecular disease of cell membrane glycoconjugates. Certain glycoconjugates are receptors for distinct bacteria. Recent studies support the understanding that shifts in the colonization of different cancer cells are linked with observed changes in cell surface receptors. It is now identified that bacteria bind to and colonize the mucosal surfaces in a very particular manner via a “lock and key” mechanism. There is a specific binding between adhesins on bacteria to complementary receptors on the mucosal surfaces of the host.[10]

Bacteria may induce carcinogenesis by the following mechanisms:[9]

  1. Stimulation of chronic inflammation
  2. Cell proliferation
  3. Inhibition of cellular apoptosis
  4. Promotion of cellular invasion
  5. Production of carcinogenic substances.[9]


Stimulation of chronic inflammation

Chronic or dysregulated inflammation plays a role in tumor development partly through the modulation of tumor microenvironment.[11]

Inflammation is triggered by infections or environmental exposures and plays a crucial role in all stages of carcinogenesis including induction, progression, invasion and metastasis.

Microorganisms and their products activate inflammatory cells, fibroblasts and epithelial cells. Reactive species such as hydrogen peroxide and oxygen radicals, reactive nitrogen species such as nitric oxides, reactive lipids and metabolites (malondialdehyde and hydorxy-2-nonenal) and matrix metalloproteases are generated by the activation of these cells. These compounds can directly affect tumor growth. They induce DNA damage in epithelial cells by activating tumor cell toll-like receptors that ultimately leads to nuclear translocation of the transcription factor nuclear factor- kappa β (NF-kβ) and cytokine production. These cytokines are formed in a dysregulated manner and play a role in cell growth, invasion and interruption of tumor suppression, immune status and even survival.

It is not clear whether these mediators are critical for the growth of tumors and/or whether they constitute a conducive habitat for the spread of malignancies. Increased levels of certain pro-inflammatory, pro-angiogenic NF-kβ-dependent cytokines such as tumor necrosis factor-α, interleukin (IL)-1, IL-6, IL-8, granulocyte-macrophage colony-stimulating factor and vascular endothelial growth factor were observed in serum, saliva and tissue specimens of patients with oral cancer.[12]

P. gingivalis and F. nucleatum persist intracellularly within the epithelial cells and can cause chronic infections and initiate inflammatory responses. They can also spread systemically and cause infections beyond the oral cavity where they cause major disruptions of the host immune response mechanisms.[13]

Cell proliferation

Bacteria can cause chronic infections or produce toxins that induce cellular proliferations and DNA replication by the activation of mitogen-activated kinase pathways and cyclin D1. This leads to disturbance in the cell cycle and alteration in cell growth. This increases tumor development through an increase in the genetic mutations.[14]

The microbial endotoxins may directly induce mutations in tumor suppressor genes and proto-oncogenes. They may also alter signaling pathways that affect multiplication of and/or survival of epithelial cells.[12]

Inhibition of apoptosis

P. gingivalis is recognized to halt the apoptosis of gingival epithelial cells by different mechanisms, hence allowing itself to sustain.[15]

The response of the epithelial cells to P. gingivalis infection is changes to apoptosis and cell division. P. gingivalis is greatly antiapoptotic and can surely suppress chemically induced apoptosis in primary cultures of gingival epithelial cells.[16] It stimulates JAK1/STAT3 and PI3K/Akt signaling. This signaling regulates intrinsic mitochondrial apoptosis pathways.[1]

Promotion of cellular invasion

P. gingivalis infection activates the ERK 1/2-Ets 1, p38/HSP27 and PAR2/NF-KB pathways. This induces the expression of promatrix metalloproteinase MMP-9. P. gingivalis also produces Gingipains, cysteine proteinases, which play a dual role in this process.

They both engage the PAR2 receptor and cleave the MMP-9 proenzyme into the mature active form. MMP-9 causes degradation of the basement membrane and extracellular matrix. This promotes the migration and invasion of the cancer cells and thus allows carcinoma cells to enter the lymphatic system and blood vessels for spread and metastatic growth at distant sites. In this way, P. gingivalis may contribute to the metastasis of OSCC.[16]

Production of carcinogenic substances

The microflora which exists in the tumor microenvironment may aid in tumorigenesis by conversion of ethanol into acetaldehyde, its carcinogenic derivative to levels which are able to induce damage to the DNA, mutagenesis and secondary hyperproliferation of the epithelium.[14] The International Agency for Research on Cancer has also classified acetaldehyde associated with alcohol consumption as a Group I carcinogen to humans.[1]

Oral bacteria are found much more commonly on the surface of primary oral cancer tissue and in the metastatic lymph nodes as compared to normal oral mucosa and nonmetastatic lymph nodes. Bacteria in the oral cavity may invade through areas of tissue surface destruction due to oral cancer and further flow into the cervical lymph nodes. This suggests a contribution of oral bacteria to progression of oral cancer.[15]


   Viruses and Oral Cancer Top


Viral infections of latent or chronic nature cause malignant transformation by interfering with the cell cycle machinery of the host. Cell growth and proliferation is affected by these viral genes and gene products. Certain viral genes are proto-oncogenes. These proto-oncogenes become oncogenes when inserted into the host's DNA and ultimately result in malignant transformation.[17]

Oncogenic viruses have the capacity to disrupt checkpoints in the cell cycle induced by genotoxic stress. P53 and connecting cellular proteins are involved in downstream activities. They are inactivated by viral antigens either by releasing cells from cell cycle checkpoints or protecting cells from the p53-dependent apoptotic pathway.[18]

DNA viruses have the capacity of transforming cells to a malignant phenotype and are found in many different cancers. HPV has been proposed as a risk factor in the development of OSCC and the most important subtype is HPV 16. Other oncogenic virus species that have been proposed to be involved in oral carcinogenesis are the Epstein–Barr virus and Herpes simplex virus type 1.[19]


   Fungi and Oral Cancer Top


It is a known fact that Candida species are normal commensals of the oral cavity in up to 50% of healthy population.[18]

Candida might induce OSCC by the production of carcinogenic compounds such as nitrosamines. The tubular hyphal structure of Candida albicans might allow the ingress of precursors from saliva and release of the nitrosamine products to keratinocytes, thus initiating OSCC.[20]

Candida species present in the oral cavity contain the enzyme alcohol dehydrogenase. This enzyme catalyzes the production of mutagenic amounts of acetaldehyde under aerobic or microaerophilic conditions.[1]


   Studies on Oral Microbiome and Oral Cancer Top


Nagy et al. in 1998 investigated the microbial contents of the biofilms by aerobic and anerobic culture methods on the surfaces of OSCCs. They concluded that human oral carcinoma surface biofilms show significantly more number of aerobes and anaerobes when compared with the healthy mucosa of the same patient.[21]

Sakamoto et al. in 1999 isolated bacteria in oral cancer patients. Viable bacteria were isolated from cervical lymph nodes from 25 patients. The most commonly isolated bacteria were oral Streptococci.[22]

Lax and Thomas in 2002 attempted to explain the role of bacteria in the causation of cancer.[23]

Morita et al. in 2003 used PCR to determine whether Streptococcus anginosus is associated with oral cancer tissues. Their results suggested that S. anginosus is not closely related with oral cancer but is associated with esophageal cancer.[24]

Muthu et al. in 2004 studied the changes in the flora in the oro-pharyngeal region in head-and-neck malignancy post radiotherapy and found a significant decrease in alpha hemolytic Streptococci and Neisseria species post radiotherapy.[25]

Chambers et al. in 2005 conducted a pilot study to examine elevated Mutans Streptococci in xerostomic cancer patients after pilocarpine therapy.[26]

Mager et al. in 2005 investigated to determine if salivary counts of oral bacteria differed in patients with OSCC and cancer-free controls and concluded that high counts of C. gingivalis, Prevotella melaninogenica and Streptococcus mitis may be diagnostic indicators of OSCC.[27]

Hooper et al. in 2006 isolated nighty species mostly bacterial from within the tissue of twenty OSCC and provided some evidence for tumor specificity of bacteria.[28]

Hooper et al. in 2007 characterized bacterial microbiota in oral cancerous lesions and noted apparent differences between the composition of tumorous and nontumorous tissues; tumorous tissue showed the presence of saccharolytic and aciduric species.[29]

Lee et al. 2010, explored the relevance of HPV infection to carcinogenesis of oral tongue cancer.[30]

Katz et al. in 2011 investigated P. gingivalis in squamous cell carcinoma specimens by immuno-histochemical staining and suggested a potential association between the bacteria and gingival squamous cell carcinoma.[31]

Pushalkar et al. in 2011 evaluated the diversity and relative abundance of bacteria in the progression of OSCC using saliva and found that majority of classified sequences belonged to phyla Firmicutes (45%) and Bacteroidetes (25%).[32]

Schmidt et al. in 2014 investigated the changes in the microbiome associated with oral cancers by profiling cancers and anatomically matched contralateral normal tissue from the same patient by sequencing 16S rDNA hypervariable region amplicons. They found a significant decrease in the abundance of Firmicutes (especially Streptococcus) and Actinobacteria (especially Rothia) relative to contralateral normal sample from the same patient.[6]

Lee et al. in 2017 investigated the differences in microbiota between normal, epithelial precursor patients and cancer patients with different lifestyles using NGS and the overall microbiome composition of five genera and revealed significant differences between epithelial precursor lesion and cancer patients.[33]

Zhao et al. in 2017 studied the variations in oral microbiota associated with oral cancer. They profiled the bacteria within OSCC lesion surface samples at the species level using NGS and comprehensively investigated bacterial community composition and functional genes in these samples and observed significantly greater bacterial diversity in cancer samples than in normal samples.[34]

Banerjee et al. in 2017 studied the microbial signature associated with oropharyngeal and OSCCs by using a pan-pathogen array technology (Pathochip) coupled with NGS. They found different microbiome signatures in OSCC tissue than those in adjacent clinically normal controls or oral tissue from otherwise healthy controls.[35]

Furquim et al. in 2017 studied salivary microbiome and oral cancer risk in Fanconi anemia patients by 16S rRNA sequencing of the V3–V4 hypervariable region and the most abundant phyla found were Firmicutes and Bacteroidetes.[36]

Mok et al. in 2017 studied the community variations in oral microbiome associated with normal, potentially malignant disorders and malignant lesions of the oral cavity using 16S rDNA sequencing. They identified a core microbiome in the form of common bacterial phyla and genera in normal, OPMD and oral cancer patients. The predominant phylum and genus were Firmicutes and Streptococcus, respectively.[37]

Yang et al. in 2018 studied oral microbiota community dynamics associated with OSCC staging. The oral microbiota communities from Stage 4 patients showed significantly higher complexity than those from healthy controls. Their results revealed changes during the progression of oral cancer. A marker panel of upregulated F. periodonticum and downregulated S. mitis and P. pasteri bacteria can discriminate OSCC Stage 4 patients from healthy controls.[38]

Hayes et al. in March 2018 examined the association between the oral microbiome and incident head-and-neck squamous cell cancer prospectively and concluded that greater oral abundance of commensal Corynebacterium and Kingella is associated with decreased risk of HNSCC.[39]

Kengo et al. in 2018 studied the changes in the oral microbiome profiles in OSCC and revealed some shifts in the oral microbial communities and concluded that salivary microbiome changes may have potential application as a useful diagnostic tool for early detection of OSCC and malignant transformation of precancerous regions. They observed that the frequency of Bacteroidetes was more abundant in OSCC patients compared with leukoplakia and normal controls. The genera Streptococcus and Rothia were significantly lower in OSCC patients compared to leukoplakia and normal controls.[40]


   Oral Microbiome in Cancer at Extra-Oral Sites Top


Oral microbiome is known to be involved in the initiation and progression of disease not only in the oral cavity, but also at distant sites.[41]

There are data suggesting that bacteria in the oral cavity play a role in tumors of the gastrointestinal tract.[8]

Bacteria and fungi present in the oral cavity and gut are also associated with the pathogenesis of colorectal cancer (CRC).[42]

P. gingivalis has been related with the promotion of CRC. Metagenomics studies using fecal samples, identify Parvimonas micra and Pasteurella stomatis bacteria from the oral cavity as markers of CRC. These bacteria have been reported in an oral microbe-induced colorectal tumorigenesis model. Hence, it is important to consider the role of oral microbial communities in the development of CRC.[43]

A study by Fan et al. provides supportive documentation that oral microbiota may play a role in the etiology of pancreatic cancer.[44]


   Omics Technologies for Oral Cancer Microbiome Research Top


The word “omics” refers to a field of study in biological sciences that ends with –omics, such as genomics, transcriptomics, proteomics or metabolomics. The ending –ome is used to describe the object of study of such fields, such as genome, transcriptome, proteome or metabolome.[45]

The microbial community can be characterized by its composition (Metagenome), by the analysis of transcripts (Metatranscriptome), by the analysis of proteins (Metaproteome) or by the analysis of the final products resulting from the collective action of the community (Metabolomics).[46]

Metagenomics

Metagenomics (meta-beyond) is the study of the genetic material of entire communities of organisms. The main purpose of metagenomics is to infer taxonomic profile of a microbial community. It is the first step to study the microbiome.[47]

It gives insight of the bacterial profiles, detects specific metabolic pathways and the associated genes.[48]

Metataxonomic sequencing is a technique in which bacterial composition of a sample is determined by PCR amplification and sequencing one or more variable regions of the 16S rRNA gene present in the bacterial genomes from the extracted DNA sample.[49]

The 16S rRNA gene is present in all prokaryotes and is a highly conserved genetic marker.[50]

16S rRNA sequencing only determines the presence or abundance of bacterial species and allows researchers to draw observational conclusions.[51]

16S rRNA gene surveys are generally quoted as metagenomics studies but they are not. In 16S rRNA gene surveys, the study is focused on a single gene used as a taxonomic marker while structural metagenomics intends to investigate the genomes of microbial community members.[52]

Metatranscriptomics

The transcriptome is the total mRNA in a cell or organism. It is the template for protein synthesis in a process called translation.[47]

It reflects the genes that are actively expressed at any given moment.[53]

Metatranscriptomics is emerging as a powerful approach for functional characterization of complex microbial communities.[54]

Metaproteomics

The proteome is defined as the set of all expressed proteins in a cell, tissue or organism. Proteomics aims to characterize information flow within the cell and organism via protein pathways and network. The eventual aim of proteomics is understanding the functional relevance of proteins.[47]

Metaproteomics allows us to study the presence and abundances of proteins in any microbial community.[55]

Metabolomics

Metabolomics can generally be defined as the study of global metabolite profiles in a system (cell, tissue or organism). It is the final downstream product of gene transcription and therefore changes in the metabolome are amplified relative to changes in the transcriptome and proteome.[47] Oral metabolomic analysis has been used for the exploration of biomarkers in different types of cancers, including oral cancer.[46]


   Conclusion Top


Human body is a host to numerous microorganisms. These microorganisms along with their genetic material form a significant part of the human body which is called as the microbiome. Alterations in the composition of the normal microbiome are referred to as dysbiosis which leads to diseased states. Microbes have been associated with oral diseases such as dental caries, periodontal diseases and many others including oral cancer. Bacteria and viruses have been implicated in the etiology of oral cancer. Microbiome research has become the current buzzword. Omics technologies have revolutionized our understanding of the microbiome. We are at an embryonic stage of microbiome research. Studies have shown alterations of the oral microbiome in oral cancer. The first step is understanding the changes in the composition of the oral microbiome from normal to precancer to cancer. The next level of research should be focusing on the functional microbiome, i.e., metagenomics, meta-transcriptomics, meta-proteomics and metabolomics. This will concentrate on the metabolic pathways, host–microbiome interactions and how the microbiome contributes to carcinogenesis, which may help in knowing why a therapy works for specific patients only. This may assist in targeted therapies, precision and personalized medicine and better treatment planning and thus contribute to health care.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Perera M, Al-Hebshi NN, Speicher DJ, Perera I, Johnson NW. Emerging role of bacteria in oral carcinogenesis: A review with special reference to perio-pathogenic bacteria. J Oral Microbiol 2016;8:32762.  Back to cited text no. 1
    
2.
Jha C, Sinha R, Sarkar S, Sen S, Jha H. Bacteria in oral carcinogenesis. J Oral Med Oral Surg Oral Pathol Oral Radiol 2018;4:164-7.  Back to cited text no. 2
    
3.
Cankovic M, Bratic MB, Loncar J, Marinoski J, Lic MP. Bacterial flora on the surface of oral squamous cell carcinoma. Arch Oncol 2013;21:62-4.  Back to cited text no. 3
    
4.
Tanaka T, Ishigamori R. Understanding carcinogenesis for fighting oral cancer. J Oncol 2011;2011:603740.  Back to cited text no. 4
    
5.
Sarode G, Sarode SC, Tupkari J, Patil S. Is oral squamous cell carcinoma unique in terms of intra and intertumoral heterogeneity? Transl Res Oral Oncol 2017;2:16.  Back to cited text no. 5
    
6.
Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, et al. Changes in abundant of oral microbiota associated with oral cancer. PLoS One 2014;9:e98741.  Back to cited text no. 6
    
7.
Srinivasprasad V, Dineshshankar J, Sathiyajeeva J, Karthikeyan M, Sunitha J, Raghunathan R. Liason between micro-organisms and oral cancer. J Pharm Bioallied Sci 2015;7 Suppl 2:S354-60.  Back to cited text no. 7
    
8.
Karpiński TM. Role of oral microbiota in cancer development. Microorganisms 2019;7:20.  Back to cited text no. 8
    
9.
Al-Hebshi NN, Borgnakke WS, Johnson NW. The microbiome of oral squamous cell carcinoma: A functional perspective. Curr Oral Health Rep 2019;6:145.  Back to cited text no. 9
    
10.
Khajuria N, Metgud R. Role of bacteria in oral carcinogenesis. Indian J Dent 2015;6:37-43.  Back to cited text no. 10
[PUBMED]  [Full text]  
11.
Kudo Y, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, et al. Oral environment and cancer. Genes Environ 2016;38:13.  Back to cited text no. 11
    
12.
Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 2012;12:144.  Back to cited text no. 12
    
13.
Faden AA. The potential role of microbes in oncogenesis with particular emphasis on oral cancer. Saudi Med J 2016;37:607-12.  Back to cited text no. 13
    
14.
Rajeev R, Choudhary K, Panda S, Gandhi N. Role of bacteria in oral carcinogenesis. South Asian J Cancer 2012;1:78-83.  Back to cited text no. 14
[PUBMED]  [Full text]  
15.
Kusama K, Inoue H, Miyazaki Y, Kikuchi K, Sakashita H, Ochiai K. Microorganisms and cancer of the oral cavity. Integr Cancer Sci Therap 2016;3:510-5.  Back to cited text no. 15
    
16.
Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog 2014;10:e1003933.  Back to cited text no. 16
    
17.
Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther 2016;12:458-63.  Back to cited text no. 17
    
18.
Gupta AA, Kheur SM, Shetty L, Kheur M. Unconventional causes of conventional oral cancer. J Clin Exp Pathol 2015;5:254.  Back to cited text no. 18
    
19.
Sand L, Jalouli J. Viruses and oral cancer. Is there a link? Microbes Infect 2014;16:371-8.  Back to cited text no. 19
    
20.
Bansal R, Pallagatti S, Sheikh S, Aggarwal A, Gupta D, Singh R. Candidal Species identification in malignant and potentially malignant oral lesions with antifungal resistance patterns. Contemp Clin Dent 2018;9:S309-13.  Back to cited text no. 20
    
21.
Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol 1998;34:304-8.  Back to cited text no. 21
    
22.
Sakamoto H, Naito H, Ohta Y, Tanakna R, Maeda N, Sasaki J, et al. Isolation of bacteria from cervical lymph nodes in patients with oral cancer. Arch Oral Biol 1999;44:789-93.  Back to cited text no. 22
    
23.
Lax AJ, Thomas W. How bacteria could cause cancer: One step at a time. Trends Microbiol 2002;10:293-9.  Back to cited text no. 23
    
24.
Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci 2003;94:492-6.  Back to cited text no. 24
    
25.
Muthu K, Raman R, Gopalakrishnan G. Oropharyngeal flora changes in patients with head and neck malignancy post radiotherapy. Med J Malaysia 2004;59:585-90.  Back to cited text no. 25
    
26.
Chambers MS, Keene HJ, Toth BB, Lemon JC, Gallagher SC, Martin CG, et al. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:180-4.  Back to cited text no. 26
    
27.
Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005;3:27.  Back to cited text no. 27
    
28.
Hooper SJ, Crean SJ, Lewis MA, Spratt DA, Wade WG, Wilson MJ. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol 2006;44:1719-25.  Back to cited text no. 28
    
29.
Hooper SJ, Crean SJ, Fardy MJ, Lewis MAO, Spratt DA, Wade WG, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol 2007;56:1651-9.  Back to cited text no. 29
    
30.
Lee SY, Cho NH, Choi EC, Baek SJ, Kim WS, Shin DH, et al. Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral Maxillofac Surg 2010;39:678-83.  Back to cited text no. 30
    
31.
Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci 2011;3:209-15.  Back to cited text no. 31
    
32.
Pushalkar S, Mane SP, Ji X, Evans C, Crasta OR, Morse D,et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 2011;61:269-77.  Back to cited text no. 32
    
33.
Lee WH, Chen HM, Yang SF, Liang C, Peng CY, Lin FM, et al. Bacterial alterations in salivary microbiota and their association in oral cancer. Sci Rep 2017;7:16540.  Back to cited text no. 33
    
34.
Zhao H, Chu M, Huang Z, Yang X, Ran S, Hu B, et al. Variations in oral microbiota associated with oral cancer. Sci Rep 2017;7:11773.  Back to cited text no. 34
    
35.
Banerjee S, Tian T, Wei Z, Wei Z, Peck KN, Shih N, et al. Microbial signatures associated with oropharyngeal and oral squamous cell carcinomas. Sci Rep 2017;7:4036.  Back to cited text no. 35
    
36.
Furquim CP, Soares GM, Ribeiro LL, Azcarate-Peril MA, Butz N, Roach J, et al. The salivary microbiome and oral cancer risk: A pilot study in Fanconi anemia. J Dent Res 2017;96:292-9.  Back to cited text no. 36
    
37.
Mok SF, Karuthan C, Cheah YK, Ngeow WC, Rosnah Z, Yap SF, et al. The oral microbiome community variations associated with normal, potentially malignant disorders and malignant lesions of the oral cavity. Malays J Pathol 2017;39:1-5.  Back to cited text no. 37
    
38.
Yang CY, Yeh YM, Yu HY, Chin CY, Hsu CW, Liu H, et al. Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Front Microbiol 2018;9:862.  Back to cited text no. 38
    
39.
Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, et al. Association of oral microbiome with risk for incident head and neck squamous cell cancer. JAMA Oncol 2018;4:358-65.  Back to cited text no. 39
    
40.
Kengo H, Shuji N, Sho H, Sei U, Ichiro Oh-Iwa, Toru N, et al. Changes of oral microbiome profiles associated with oral squamous cell carcinoma. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018, 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR. Cancer Res 2018;78 13 Suppl: 5123.  Back to cited text no. 40
    
41.
Lim Y, Totsika M, Morrison M, Punyadeera C. Oral microbiome: A new biomarker reservoir for oral and oropharyngeal cancers. Theranostics 2017;7:4313-21.  Back to cited text no. 41
    
42.
Klimesova K, Jiraskova Zakostelska Z, Tlaskalova-Hogenova H. Oral bacterial and fungal microbiome impacts colorectal carcinogenesis. Front Microbiol 2018;9:774.  Back to cited text no. 42
    
43.
Vale S. Indirect targeting of cancers via oral microbiome modification. J Cancer Res Immunooncol 2017;3:110.  Back to cited text no. 43
    
44.
Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, et al. Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study. Gut 2018;67:120-7.  Back to cited text no. 44
    
45.
Vailati-Riboni M, Palombo V, Loor JJ. What are omics sciences? In: Ametaj B, editors. Periparturient Diseases of Dairy Cows. Cham: Springer; 2017.  Back to cited text no. 45
    
46.
Duran-Pinedo AE, Frias-Lopez J. Beyond microbial community composition: Functional activities of the oral microbiome in health and disease. Microbes Infect 2015;17:505-16.  Back to cited text no. 46
    
47.
Aguiar-Pulido V, Huang W, Suarez-Ulloa V, Cickovski T, Mathee K, Narasimhan G. Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol Bioinform Online 2016;12:5-16.  Back to cited text no. 47
    
48.
Xu P, Gunsolley J. Application of metagenomics in understanding oral health and disease. Virulence 2014;5:424-32.  Back to cited text no. 48
    
49.
Mullish BH, Osborne LS, Marchesi JR, McDonald JA. The implementation of omics technologies in cancer microbiome research. Ecancermedicalscience 2018;12:864.  Back to cited text no. 49
    
50.
Graña-Castro O, López-Fernández H, Fdez-Riverola F, Al-Shahrour F, Glez-Peña D. Proposal of a new bioinformatics pipeline for metataxonomics in precision medicine. In: Fdez-Riverola F, Rocha M, Mohamad M, Zaki N, Castellanos-Garzón J, editors. Practical Applications of Computational Biology and Bioinformatics, 13th International Conference. PACBB 2019. Advances in Intelligent Systems and Computing. Vol. 1005. Cham: Springer; 2020.  Back to cited text no. 50
    
51.
Deo PN, Deshmukh R. Oral microbiome: Unveiling the fundamentals. J Oral Maxillofac Pathol 2019;23:122-8.  Back to cited text no. 51
[PUBMED]  [Full text]  
52.
de Fátima Alves L, Westmann CA, Lovate GL, Viana de Siqueira GM, Borelli TC, Guazzaroni ME. Metagenomic approaches for understanding new concepts in microbial science. Int J Genomics 2018;2018:2312987.  Back to cited text no. 52
    
53.
Verma M. Mechanistic and technical challenges in studying the human microbiome and cancer epidemiology. Technol Cancer Res Treat 2017;16:150-8.  Back to cited text no. 53
    
54.
Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A, et al. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci 2018;10:32.  Back to cited text no. 54
    
55.
Suzuki T, Uchiyama M. Inhibitory effect of parathion on the photosynthetic electron transport system in isolated spinach chloroplasts. Bull Environ Contam Toxicol 1975;14:552-7.  Back to cited text no. 55
    




 

Top
Print this article  Email this article
            

    

 
   Search
 
  
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Article in PDF (521 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
    Bacteria and Ora...
    Viruses and Oral...
    Fungi and Oral C...
    Studies on Oral ...
    Oral Microbiome ...
    Omics Technologi...
   Conclusion
    References

 Article Access Statistics
    Viewed227    
    Printed4    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal

Journal of Oral and Maxillofacial Pathology | Published by Wolters Kluwer - Medknow
Online since 15th Aug, 2007